Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from AbbVie Inc

What You Need to Know Ahead of AbbVie’s Earnings Release

AbbVie will release its first-quarter earnings this month, and analysts anticipate a double-digit bottom-line growth.

Barchart

3 Dividend Kings Delivering Generational Income & Market-Beating Returns

3 top-performing Dividend Kings of 2025 based on their Year-to-Date percent change.

Barchart

Qualcomm, Aptiv, Palo Alto And A Health Care Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades” on Tuesday, Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, said he is staying long on AbbVie Inc. (NYSE:ABBV).

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Amazon, AbbVie, Datadog And A Financial Stock: CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” on Monday, Jim Lebenthal, partner at Cerity Partners, said AbbVie Inc (NYSE:ABBV) has gained 30% this year. The stock has a good dividend yield and also has an attractive valuation, he added.

Benzinga

5 Dividend Kings For Generations Of Passive Income

These are five Dividend Kings, companies with 50+ years of dividend increases, covering recent developments, dividend safety, and valuation, so you can identify candidates for durable income that fit your goals.

Barchart

AbbVie Soars On Skyrizi And Rinvoq Strength, Outpacing Humira Erosion

On Thursday, AbbVie Inc. (NYSE:ABBV) reported second-quarter 2025 sales of $15.42 billion on Thursday, beating the consensus of $14.98 billion.

Benzinga

Why Is AbbVie Stock Trading Higher On Thursday?

IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation Inc., and AbbVie Inc. (NYSE:ABBV), on Thursday, announced an exclusive licensing agreement for IGI’s lead investigational asset, ISB 2001, developed using IGI’s proprietary BEAT protein platform, for oncology and autoimmune diseases.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

3 Dividend Growth Stocks To Buy and Hold Forever

These three companies have a high 5-year dividend yield, providing long-term stability while maximizing income.

Barchart

3 Dividend Kings You’ll Regret Ignoring - Wall Street Sees Big Upside in These Picks

These three high-yield Dividend Kings have strong buy ratings and impressive growth potential, and analysts see big upside in these names.

Barchart

3 Healthcare Stocks Tackling America’s Biggest Medical Challenges

From breakthrough treatments to AI-driven diagnostics, healthcare is evolving faster than ever. With increasing healthcare spending and innovative technologies transforming patient care, companies like AbbVie (ABBV), Gilead Sciences (GILD), and Bristol-Myers Squibb (BMY) are tackling some of the biggest challenges and could be poised for long-term growth. Read more….

StockNews.com

3 Dividend Growth Stocks for Long-Term Wealth

Dividend-growth stocks offer steady income and long-term value. With the Fed holding rates and inflation expected to ease, now is an opportune time to invest in companies like AbbVie (ABBV), Energy Transfer (ET), and Cheniere Energy (CQP) that consistently raise payouts. Read more….

StockNews.com

3 High-Conviction Stocks with Strong Buy Ratings from Analysts

It’s easy to get caught up in market noise, but investing in companies backed by strong fundamentals and long-term growth potential can help investors stay the course even during market volatility. Thus, one could consider adding these three high-conviction pharmaceutical stocks, AbbVie (ABBV), Merck & Co. (MRK), and Bristol-Myers Squibb…

StockNews.com

3 Blue-Chip Stocks with Strong Buy Ratings from Analysts

As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability and long-term growth potential. Thus, one could consider adding these three fundamentally sound blue-chip stocks, AbbVie (ABBV), Merck & Co. (MRK), and Johnson & Johnson (JNJ), with Strong Buy ratings from…

StockNews.com

3 High-Potential Dividend Growth Stocks for 2024

In times of market volatility, driven by geopolitical risks and political uncertainty, dividend growth stocks offer stability and reliable income. Hence, investing in Home Depot (HD), AbbVie (ABBV), and Lowe's Companies (LOW) stocks could be a wise choice for investors seeking long-term growth and consistent cash flow. Read more….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Healthcare Stocks Leading the Fight Against Global Diseases

As chronic and infectious diseases continue to rise, the demand for advanced healthcare solutions grows. Hence, investing in established healthcare stocks, Pfizer (PFE), Merck & Co (MRK), and AbbVie (ABBV), presents a compelling opportunity to capitalize on the sector’s landscape. Read on….

Barchart

3 Oversold Dividend Aristocrats Ready To Explode in 2025

These three companies all have one thing in common: they are all on sale.

StockNews.com

3 Dividend Powerhouses Yielding Over 3% to Consider

Dividend stocks are attractive for their steady income, stability, and growth potential, especially amid low interest rates and economic uncertainties. Against this backdrop, income-seeking investors may want to consider high-dividend stocks yielding over 3%, such as AbbVie (ABBV), Coca-Cola (KO), and AT&T (T). Keep reading.

StockNews.com

3 Dividend Growth Stocks for Long-Term Investors

Dividend growth stocks offer a unique blend of reliability and growth potential, making them an ideal choice for long-term investors. Therefore, you might consider watching stocks like The Home Depot (HD), AbbVie (ABBV), and McDonald's Corp (MCD) for long-term investments. Read on….

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Healthcare Stocks to Buy for the Aging Population Boom

The rapidly growing aging population is driving expansion in healthcare, with rising demand for treatments and chronic disease management. Companies like AbbVie (ABBV), Medtronic (MDT), and Centene (CNC) are well-positioned to meet these needs, making them attractive options for investors seeking to capitalize on the industry’s sustained growth potential. Read…

StockNews.com

3 Healthcare Stocks to Buy for an Aging Population Boom

As the global population ages, demand for healthcare solutions are expected to surge. As a result, investors might consider fundamentally solid healthcare stocks UnitedHealth Group, AbbVie, and Merck & Co., which are poised to benefit from the aging population boom. Keep reading.

StockNews.com

3 Healthcare Stocks for Safe, Steady Growth

The healthcare industry is set for growth due to the growing demand for quality healthcare services and ongoing advancements in medical technology. Hence, investors might consider investing in healthcare stocks, Johnson & Johnson (JNJ), AbbVie (ABBV), and Thermo Fisher Scientific (TMO) for safe and steady growth. Read more….

StockNews.com

3 Pharmaceutical Stocks That Could Lead the Next Drug Revolution

The pharmaceutical industry is promising due to AI and biotech innovations enhancing productivity, steady profits amidst economic shifts, rising chronic illnesses, and strong growth projections in global revenues and biotechnology markets. Therefore, it could be wise to invest in pharma stocks such as AbbVie (ABBV), Bristol-Myers Squibb (BMY), and Gilead…

StockNews.com

3 High-Dividend Pharma Blue Chips That Are on Sale Right Now

With the Federal Reserve potentially cutting interest rates for the first time in over four years, uncertainty looms in the market. Amid this backdrop, it could be wise to scoop up the shares of fundamentally sound pharma stocks like AbbVie (ABBV), Novartis (NVS), and Pfizer (PFE), which are not just…

StockNews.com

3 Healthcare Stocks Benefiting From Aging Populations

The healthcare industry is thriving, owing to the growing healthcare expenditure and aging population. Given the industry’s tailwinds, fundamentally sound healthcare stocks AbbVie (ABBV), Boston Scientific (BSX), and CVS Health (CVS) could be solid buys. Keep Reading….

StockNews.com

3 Healthcare Stocks With Strong Buy Ratings

The healthcare sector is proving to be a robust investment haven, particularly as it continues to evolve with groundbreaking technology and strong government support. Therefore, adding strong A-rated stocks like Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck & Co. (MRK) could help garner significant returns. Read more….

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.